Elsevier

Ophthalmology

Volume 128, Issue 4, April 2021, Pages 494-503
Ophthalmology

Original Article
Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19

https://doi.org/10.1016/j.ophtha.2020.08.029Get rights and content

Purpose

To investigate the presence of SARS-CoV-2 RNA in tears of patients with moderate to severe coronavirus disease 2019 (COVID-19).

Design

Cross-sectional study.

Participants

Patients with laboratory-proven moderate to severe COVID-19.

Methods

Tears were collected within 48 hours of laboratory confirmation using 3 methods: conjunctival swab plus Schirmer’s test strips (group 1), conjunctival swab (group 2), and Schirmer’s test strips (group 3). Samples from both the eyes of each patient were transported in a single viral transport media for real-time RT-PCR. Detailed demographic profiles, systemic symptoms, comorbidities, and ocular manifestations were noted.

Main Outcome Measures

Viral load of a sample was determined using cycle threshold (Ct) value of E gene. A specimen was considered to show positive results if the amplification curve for the E gene crossed the threshold line within 35 cycles and if it showed positive results on an RNA-dependent RNA polymerase or open reading frame 1b gene assay.

Results

Of the 78 patients enrolled in the study, samples from 3 patients were found to be inadequate for analysis. Thirty-six patients (48%) had moderate disease, whereas 39 patients (52%) had severe disease, with no ocular involvement in any patient. In the 75 patients, RT-PCR analysis of tears showed positive results in 18 patients (24%), and 29 of 225 samples (12.9%) showed positive results. Positive results were found in 11 (14.7%), 11 (14.7%), and 7 (9.3%) patients in groups 1, 2, and 3, respectively (P = 0.3105). Mean Ct values in groups 1, 2, and 3 were 28.36 ± 6.15, 29.00 ± 5.58, and 27.86 ± 6.46 (P = 0.92), respectively. Five patients showed positive RT-PCR results by all 3 methods (mean Ct value, 25.24 ± 6.33), and 12 patients showed positive results by any of the 3 methods (mean Ct value, 32.16 ± 1.94), the difference in Ct values being statistically significant (P = 0.029). The median value of symptomatology in patients with positive RT-PCR results from tears was 5 days (range, 4–9 days).

Conclusions

SARS-CoV-2 RNA was detected in tears of 24% of patients with laboratory-proven moderate to severe COVID-19. Conjunctival swab remains the gold standard of tear collection for RT-PCR assay. A significantly higher possibility of viral transmission exists through tears in patients with moderate to severe COVID-19.

Section snippets

Methods

A cross-sectional study was conducted from May 22 through June 4, 2020, in Lok Nayak Hospital, New Delhi, India, one of the largest, tertiary, COVID-19–dedicated hospitals in North India. After obtaining the Maulana Azad Medical College institutional ethics committee clearance, the trial was registered (identifier, CTRI/2020/05/025291). Adult patients with moderate and severe laboratory-confirmed COVID-19 with positive results from naso-oropharyngeal RT-PCR analysis, performed 1 day before, who

Results

Of the 78 patients enrolled in the study, only 75 were considered for analysis because samples from 3 patients were found to be inadequate for analysis (Table 1). Thirty-six of the patients (48%) had moderate disease, whereas 39 patients (52%) had severe COVID-19. The cohort comprised 41 men (54.7%) and 34 women (45.3%) ranging in age from 18 to 81 years. Fifty-six patients (74.7%) had an associated systemic comorbidity. The various comorbidities included hypertension (42%), diabetes mellitus

Discussion

The role of the ocular surface as a possible portal of entry, reservoir for replication, and transmission of SARS-CoV-2 RNA has been explored extensively.9,23, 24, 25 Differences in detection of viral RNA in tears have ranged from 0% to 7%, with some researchers claiming minimal viral shedding in ocular secretions.13, 14, 15, 16, 17, 18, 19 Recently, live virus has been demonstrated in ocular fluids by demonstrating cytopathic effect in Vero E6 cells.26 Although initial reports included

References (30)

  • P.C. Woo et al.

    Coronavirus diversity, phylogeny and interspecies jumping

    Exp Biol Med

    (2009)
  • L. Liang et al.

    There may be virus in conjunctival secretion of patients with COVID-19

    Acta Ophthalmol

    (2020)
  • J. Lan et al.

    Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

    Nature

    (2020)
  • J. Shang et al.

    Structural basis of receptor recognition by SARS-CoV-2

    Nature

    (2020)
  • S. Sadhu et al.

    COVID-19: limiting the risks for eye care professionals

    Ocul Immunol Inflamm

    (2020)
  • Cited by (82)

    • The renin-angiotensin system in the eye

      2023, Angiotensin: From the Kidney to Coronavirus
    View all citing articles on Scopus

    Supplemental material available at www.aaojournal.org.

    Disclosure(s): All authors have completed and submitted the ICMJE disclosures form. The author(s) have no proprietary or commercial interest in any materials discussed in this article.

    HUMAN SUBJECTS: Human subjects were included in this study. After obtaining the institutional ethics committee clearance at Maulana Azad Medical College, the trial was registered (CTRI/2020/05/025291). In accordance with the Declaration of Helsinki, written informed consent was obtained from all the patients.

    No animal subjects were included in this study.

    Author Contributions:

    Conception and design: Arora, Goel

    Analysis and interpretation: Arora, Goel, Saxena, Manchanda

    Data collection: Arora, Goel, Kumar, Chhabra, Saxena, Manchanda, Pumma

    Obtained funding: N/A; Study was performed as part of the authors' regular employment duties. No additional funding was provided.

    Overall responsibility: Arora, Goel

    View full text